Corient Private Wealth LP Acquires Shares of 2,704 Chemed Corporation $CHE

Corient Private Wealth LP acquired a new stake in shares of Chemed Corporation (NYSE:CHE) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,704 shares of the company’s stock, valued at approximately $1,259,000.

Several other hedge funds have also recently modified their holdings of CHE. Northwestern Mutual Wealth Management Co. lifted its stake in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after purchasing an additional 5,549,876 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Chemed in the second quarter worth about $691,290,000. Norges Bank bought a new position in Chemed during the fourth quarter valued at approximately $76,067,000. AQR Capital Management LLC boosted its stake in Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after buying an additional 153,469 shares during the last quarter. Finally, Victory Capital Management Inc. grew its holdings in Chemed by 1,260.2% during the 4th quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock valued at $50,353,000 after buying an additional 109,033 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 0.7%

CHE stock opened at $520.82 on Friday. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The stock has a market capitalization of $6.81 billion, a price-to-earnings ratio of 26.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The firm’s fifty day simple moving average is $516.70 and its two-hundred day simple moving average is $451.82.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. During the same period in the prior year, the company posted $4.27 EPS. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were paid a dividend of $0.70 per share. The ex-dividend date of this dividend was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio is 14.06%.

Analysts Set New Price Targets

Several analysts have recently issued reports on CHE shares. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Royal Bank Of Canada boosted their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Bank of America reissued a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Oppenheimer upped their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Chemed has an average rating of “Hold” and a consensus price target of $530.75.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the sale, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $37,991,215.18. The trade was a 2.76% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the transaction, the executive vice president directly owned 13,912 shares in the company, valued at approximately $7,526,948.48. This trade represents a 6.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 6,537 shares of company stock worth $3,406,014 in the last 90 days. 3.33% of the stock is owned by insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.